IMTX
Price
$8.79
Change
+$0.04 (+0.46%)
Updated
Sep 11 closing price
Capitalization
1.34B
66 days until earnings call
Intraday BUY SELL Signals
PMCB
Price
$0.45
Change
+$0.01 (+2.27%)
Updated
Sep 11 closing price
Capitalization
4.83M
Intraday BUY SELL Signals
Interact to see
Advertisement

IMTX vs PMCB

IMTX vs PMCB Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMTX vs. PMCB commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Hold and PMCB is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMTX($1.34B) has a higher market cap than PMCB($4.83M). IMTX has higher P/E ratio than PMCB: IMTX (27.61) vs PMCB (13.74). IMTX YTD gains are higher at: -16.286 vs. PMCB (-37.845). PMCB has higher annual earnings (EBITDA): -5.38M vs. IMTX (-193.88M). IMTX has more cash in the bank: 393M vs. PMCB (20.5M). PMCB has less debt than IMTX: PMCB (75.2K) vs IMTX (14.6M). IMTX has higher revenues than PMCB: IMTX (41.7M) vs PMCB (0).
IMTXPMCBIMTX / PMCB
Capitalization1.34B4.83M27,696%
EBITDA-193.88M-5.38M3,601%
Gain YTD-16.286-37.84543%
P/E Ratio27.6113.74201%
Revenue41.7M0-
Total Cash393M20.5M1,917%
Total Debt14.6M75.2K19,415%
FUNDAMENTALS RATINGS
IMTX vs PMCB: Fundamental Ratings
IMTX
PMCB
OUTLOOK RATING
1..100
7370
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
5688
P/E GROWTH RATING
1..100
542
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PMCB's Valuation (68) in the null industry is in the same range as IMTX (80). This means that PMCB’s stock grew similarly to IMTX’s over the last 12 months.

PMCB's Profit vs Risk Rating (100) in the null industry is in the same range as IMTX (100). This means that PMCB’s stock grew similarly to IMTX’s over the last 12 months.

PMCB's SMR Rating (96) in the null industry is in the same range as IMTX (98). This means that PMCB’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's Price Growth Rating (56) in the null industry is in the same range as PMCB (88). This means that IMTX’s stock grew similarly to PMCB’s over the last 12 months.

PMCB's P/E Growth Rating (2) in the null industry is somewhat better than the same rating for IMTX (54). This means that PMCB’s stock grew somewhat faster than IMTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMTXPMCB
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 13 days ago
78%
Bullish Trend about 1 month ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 2 days ago
84%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (IMTX: $8.79 vs. PMCB: $0.45)
Brand notoriety: IMTX and PMCB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 72% vs. PMCB: 50%
Market capitalization -- IMTX: $1.34B vs. PMCB: $4.83M
IMTX [@Biotechnology] is valued at $1.34B. PMCB’s [@Biotechnology] market capitalization is $4.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green while PMCB’s FA Score has 1 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • PMCB’s FA Score: 1 green, 4 red.
According to our system of comparison, PMCB is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 3 TA indicator(s) are bullish while PMCB’s TA Score has 4 bullish TA indicator(s).

  • IMTX’s TA Score: 3 bullish, 6 bearish.
  • PMCB’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PMCB is a better buy in the short-term than IMTX.

Price Growth

IMTX (@Biotechnology) experienced а -8.05% price change this week, while PMCB (@Biotechnology) price change was -7.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

IMTX is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
IMTX
Daily Signal:
Gain/Loss:
PMCB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIVOX15.50N/A
N/A
Fidelity Advisor International Value C
VITSX181.68N/A
N/A
Vanguard MStar Total Stk Mkt Idx Instl
GSPRX33.37N/A
N/A
Goldman Sachs Large Cap Equity R
FGNCX12.16N/A
N/A
Nuveen Global Infrastructure C
MSGGX12.65N/A
N/A
Meridian Small Cap Growth Legacy

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with SLDB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+0.46%
SLDB - IMTX
50%
Loosely correlated
-4.08%
VKTX - IMTX
49%
Loosely correlated
-0.47%
VIR - IMTX
49%
Loosely correlated
+0.38%
EDIT - IMTX
48%
Loosely correlated
+1.89%
RXRX - IMTX
47%
Loosely correlated
+1.27%
More

PMCB and

Correlation & Price change

A.I.dvisor tells us that PMCB and FATE have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PMCB and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMCB
1D Price
Change %
PMCB100%
+2.06%
FATE - PMCB
33%
Poorly correlated
-0.86%
CAPR - PMCB
31%
Poorly correlated
+0.84%
LTRN - PMCB
31%
Poorly correlated
-2.84%
IMTX - PMCB
30%
Poorly correlated
+0.46%
KZIA - PMCB
29%
Poorly correlated
+1.63%
More